Alzheimer Disease
Company announces acceptance of DURIN IND application and clinical protocol
Published in Women's Health Weekly, January 20th, 2005
DURECT Corp. (DRRX), an emerging specialty-pharmaceutical systems company, and Voyager Pharmaceutical Corp., a privately held specialty-pharmaceutical company focused on diseases of aging, announced the acceptance of the investigational new drug application (IND) and clinical protocol by the FDA (U.S. Food and Drug Administration) for a DURIN-based leuprolide acetate treatment of Alzheimer disease under development.
This trial will consist of a pharmacokinetic study in normal, healthy volunteers. The objectives of the clinical study are to determine the safety and tolerability of the DURIN leuprolide implant, as well as evaluate the pharmacokinetic profile of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Chronic Kidney Disease
Oral estradiol dose for postmenopausal women with CKD should be cut 50% or more - Complementary and Alternative Medicine
Further study needed on safety of St. John's wort during pregnancy, lactation - Coronary Heart Disease
Revascularization: Gender and age inequities remain in the U.K. - Obstetrics
Latest data show alcohol use rates stable among pregnant women in U.S. - Urology
Urge incontinence, bladder dysfunction may indicate occult neurological disease - Alzheimer Disease
Women bear double burden: Caregiving and higher risk of developing AD - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
